Phibro Animal Health Co. (NASDAQ:PAHC) Shares Acquired by American Century Companies Inc.

American Century Companies Inc. increased its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 18.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 635,599 shares of the company's stock after purchasing an additional 96,787 shares during the period. American Century Companies Inc. owned 1.57% of Phibro Animal Health worth $13,348,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Geode Capital Management LLC raised its stake in shares of Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after purchasing an additional 27,201 shares during the last quarter. Barclays PLC raised its position in Phibro Animal Health by 25.7% during the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after buying an additional 29,271 shares during the last quarter. FMR LLC lifted its stake in shares of Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after acquiring an additional 7,270 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after acquiring an additional 729 shares in the last quarter. Finally, Smith Group Asset Management LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter worth about $541,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC opened at $21.97 on Wednesday. The firm has a market capitalization of $889.85 million, a price-to-earnings ratio of 45.77, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The business's 50 day simple moving average is $22.80 and its 200-day simple moving average is $22.69. Phibro Animal Health Co. has a 12 month low of $12.17 and a 12 month high of $26.55.

Remove Ads

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, equities analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Barclays raised their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Finally, StockNews.com lowered Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.